Supplementary Table 1, Supplementary Table 2A, Supplementary Table 2B, Supplementary Table 3, Supplementary Table 4, or Supplementary Table 5 from TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy

Autor: Heinz-Josef Lenz, Nobuyuki Mizunuma, Wataru Ichikawa, Martin D. Berger, Satoshi Okazaki, Anish Parekh, Yan Ning, Dongyun Yang, Masashi Ueno, Ana Sebio, Yu Sunakawa, Diana L. Hanna, Shu Cao, Wu Zhang, Satoshi Matsusaka
Rok vydání: 2023
Popis: Supplementary Table 1. Summary of EMT-related SNPs Supplementary Table 2A. Association between baseline characteristics and clinical outcomes in the bevacizumab cohort Supplementary Table 2B. Association between baseline characteristics and clinical outcomes in the cetuximab cohort Supplementary Table 3. Association between TWIST1 rs2285682 and clinical outcomes in KRAS wild-type and mutant subgroups among the bevacizumab cohort Supplementary Table 4. Association between EMT-related SNPs and clinical outcomes stratified by gender in the bevacizumab cohort Supplementary Table 5. Association between TWIST1 rs2285682 and clinical outcomes in the cetuximab cohort
Databáze: OpenAIRE